<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="50392">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02059629</url>
  </required_header>
  <id_info>
    <org_study_id>CR014</org_study_id>
    <nct_id>NCT02059629</nct_id>
  </id_info>
  <brief_title>Eluna Family / Sentus BP Master Study</brief_title>
  <official_title>Eluna Family / Sentus BP Master Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Biotronik SE &amp; Co. KG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Biotronik SE &amp; Co. KG</source>
  <oversight_info>
    <authority>Germany: Federal Institute for Drugs and Medical Devices</authority>
    <authority>Austria: Austrian Medicines and Medical Devices Agency</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Eluna Family / Sentus BP Master Study is designed to confirm the safety of the new Eluna
      pacemaker family and the Sentus BP (bipolar) left ventricular lead.

      Furthermore the new wandless RF telemetry function &quot;SafeSync&quot; and the handling of the Sentus
      lead during implantation will be assessed.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Anticipated">April 2016</completion_date>
  <primary_completion_date type="Anticipated">February 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Eluna pacemaker family: Serious Adverse Device Effect (SADE) - free rate</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>The safety of the Eluna pacemaker family will be evaluated by asking the investigator to record any adverse event. While all adverse events have to be recorded throughout the study, only the number of SADEs possibly or securely related to the pacemaker will be the basis for endpoint calculation of the SADE-free rate.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sentus BP lead: Serious Adverse Device Effect (SADE) - free rate</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>The safety of the Sentus BP left ventricular lead will be evaluated by asking the investigator to record any adverse event. While all adverse events have to be recorded throughout the study, only the number of SADEs possibly or securely related to the Sentus BP lead will be the basis for endpoint calculation of the SADE free rate.</description>
  </primary_outcome>
  <other_outcome>
    <measure>Collection of data of interest: Handling assessment of Sentus lead during implantation</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>Collection of further data of interest: Evaluation of wandless RF telemetry function &quot;SafeSync&quot; in the Eluna pacemaker family</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Bradycardia</condition>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Group A: Eluna pacemaker family</arm_group_label>
    <description>Patients with standard indication for pacemaker therapy or Cardiac Resynchronization Therapy (CRT), who will be implanted with a pacemaker or CRT device of the Eluna pacemaker family. Single-, Dual- and Tripple-chamber pacemakers are applicable.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B: Sentus BP lead</arm_group_label>
    <description>Heart failure patients with indication for Cardiac Resynchronization Therapy (CRT) therapy, who will be implanted with the left ventricular Sentus BP lead. Patients can receive either CRT pacemaker or CRT-D (CRT with defibrillator function).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Eluna pacemaker family</intervention_name>
    <description>New pacemaker generation with new functions, like wandless RF telemetry &quot;SafeSync&quot;</description>
    <arm_group_label>Group A: Eluna pacemaker family</arm_group_label>
    <other_name>Eluna SR-T/DR-T/HF-T</other_name>
    <other_name>Etrinsa SR-T/DR-T/HF-T</other_name>
    <other_name>Epyra SR-T/DR-T/HF-T</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sentus BP lead</intervention_name>
    <description>over-the-wire (OTW), bipolar (BP), L-shaped (L), 4.8 French left ventricular lead</description>
    <arm_group_label>Group B: Sentus BP lead</arm_group_label>
    <other_name>Sentus OTW BP L</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients will be recruited from available pacemaker or CRT patients directly by the
        treating physician at the investigational site
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient is willing to participate in the study and provided written informed
             consent

          -  Patient meets standard indication for pacemaker or CRT-P or CRT-D therapy

          -  Patient accepts Home MonitoringÂ® concept

          -  Patient has legal capacity and ability to consent

        Exclusion Criteria:

          -  Patient with any contraindication to pacemaker and CRT-P and CRT-D therapy

          -  Patient under the age of 18

          -  Pregnant or breast-feeding women

          -  Cardiac surgery planned within the next 6 months

          -  Life expectancy less than 12 months

          -  Participation in another cardiac clinical investigation with active treatment arm

          -  Group B only: Currently implanted with an endocardial or epicardial LV lead or had
             prior attempt to place a LV lead (for CRT implants only)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Georges Mairesse, Dr. med</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cliniques du Sud Luxembourg</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Evelyn Diessel, Dr.</last_name>
    <phone>0049 30 68905 1231</phone>
    <email>evelyn.diessel@biotronik.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Peninsular Private Hospital</name>
      <address>
        <city>Frankston</city>
        <state>Victoria</state>
        <zip>3199</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Palananda Arunothayaraj, Dr.</last_name>
    </contact>
    <investigator>
      <last_name>Palananda Arunothayaraj, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Allgemeines Krankenhaus Linz</name>
      <address>
        <city>Linz</city>
        <zip>4020</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Clemens Steinwender, Dr.</last_name>
    </contact>
    <investigator>
      <last_name>Clemens Steinwender, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cliniques du Sud Luxembourg</name>
      <address>
        <city>Arlon</city>
        <zip>6700</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Georges Mairesse, Dr.</last_name>
    </contact>
    <investigator>
      <last_name>Georges Mairesse, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ZOL Genk</name>
      <address>
        <city>Genk</city>
        <zip>3600</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Wilfried Mullens, Prof. Dr.</last_name>
    </contact>
    <investigator>
      <last_name>Wilfried Mullens, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Aalborg Sygehus</name>
      <address>
        <city>Aalborg</city>
        <zip>9000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ole Eschen, Dr.</last_name>
    </contact>
    <investigator>
      <last_name>Ole Eschen, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gentofte Hospital</name>
      <address>
        <city>Hellerup</city>
        <zip>2900</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jens Haarbo, Dr.</last_name>
    </contact>
    <investigator>
      <last_name>Jens Haarbo, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Odense University Hospital</name>
      <address>
        <city>Odense</city>
        <zip>5000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jens Brock Johansen, Dr.</last_name>
    </contact>
    <investigator>
      <last_name>Jens Brock Johansen, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CharitÃ© UniversitÃ¤tsmedizin Berlin, CBF: Campus Benjamin Franklin</name>
      <address>
        <city>Berlin</city>
        <zip>12203</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Matthias Roser, Dr.</last_name>
    </contact>
    <investigator>
      <last_name>Matthias Roser, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CharitÃ© - UniversitÃ¤tsmedizin Berlin, CVK: Campus Virchow-Klinikum</name>
      <address>
        <city>Berlin</city>
        <zip>13353</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Florian Blaschke, Dr. med.</last_name>
    </contact>
    <investigator>
      <last_name>Florian Blaschke, PD Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinikum Lippe</name>
      <address>
        <city>Detmold</city>
        <zip>32756</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Johannes Brockmeier, Dr.med</last_name>
    </contact>
    <investigator>
      <last_name>Johannes Brockmeier, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UniversitÃ¤tsklinikum Erlangen, Medizinische Klinik 2</name>
      <address>
        <city>Erlangen</city>
        <zip>91054</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Martin Arnold, Dr.med.</last_name>
    </contact>
    <investigator>
      <last_name>Martin Arnold, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UniversitÃ¤tsklinikum Essen, Westdeutsches Herzzentrum Essen</name>
      <address>
        <city>Essen</city>
        <zip>45122</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nico Reinsch, OA Dr.</last_name>
    </contact>
    <investigator>
      <last_name>Nico Reinsch, OA Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Elisabeth Krankenhaus Essen</name>
      <address>
        <city>Essen</city>
        <zip>45138</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dietmar Schmitz, Dr.</last_name>
    </contact>
    <investigator>
      <last_name>Dietmar Schmitz, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UniversitÃ¤ts-Herzzentrum Freiburg</name>
      <address>
        <city>Freiburg</city>
        <zip>79106</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Thomas Faber, Dr.</last_name>
    </contact>
    <investigator>
      <last_name>Thomas Faber, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UniversitÃ¤tsmedizin Greifswald</name>
      <address>
        <city>Greifswald</city>
        <zip>17475</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mathias Busch, OA Dr.</last_name>
    </contact>
    <investigator>
      <last_name>Mathias Busch, OA</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UniversitÃ¤tsklinikum Schleswig-Holstein, Campus Kiel</name>
      <address>
        <city>Kiel</city>
        <zip>24105</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hendrik Bonnemeier, Prof. Dr.</last_name>
    </contact>
    <investigator>
      <last_name>Hendrik Bonnemeier, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Marien-Hospital LÃ¼nen</name>
      <address>
        <city>LÃ¼nen</city>
        <zip>44534</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Christian Perings, Prof. Dr.</last_name>
    </contact>
    <investigator>
      <last_name>Christian Perings, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Marienhaus GmbH St. Elisabeth Krankenhaus Saarlouis</name>
      <address>
        <city>Saarlouis</city>
        <zip>66740</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Erik Friedrich, PD Dr.</last_name>
    </contact>
    <investigator>
      <last_name>Erik Friedrich, PD Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Antonius Ziekenhuis Nieuwegein</name>
      <address>
        <city>Nieuwegein</city>
        <zip>3435</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lucas Boersma, Dr. med.</last_name>
    </contact>
    <investigator>
      <last_name>Lucas Boersma, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UniversitÃ¤tsspital Basel</name>
      <address>
        <city>Basel</city>
        <zip>4031</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Christian Sticherling, Prof. Dr.</last_name>
    </contact>
    <investigator>
      <last_name>Christian Sticherling, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kantonspital St. Gallen</name>
      <address>
        <city>St. Gallen</city>
        <zip>9007</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Peter Ammann, Prof. Dr.</last_name>
    </contact>
    <investigator>
      <last_name>Peter Ammann, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Denmark</country>
    <country>Germany</country>
    <country>Netherlands</country>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 14, 2014</lastchanged_date>
  <firstreceived_date>February 7, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Heart failure</keyword>
  <keyword>Eluna pacemaker family</keyword>
  <keyword>Sentus OTW BP L left ventricular lead</keyword>
  <keyword>Bradycardia</keyword>
  <keyword>SADE-free rate</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Bradycardia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
